Global Medical Bioplastic 麻豆原创 Research Report 2024

Publication ID:

PB506250518

Publication Date:

June 27, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Specialty Chemicals [2]

Manufacturing (Chemicals) [3]

Chemicals [4]

Description:

Medical bioplastics are a type of plastic material that is derived from renewable sources and designed to be biocompatible and environmentally friendly. These bioplastics have applications in the medical and healthcare industry due to their potential benefits in reducing waste, minimizing environmental impact, and promoting better patient outcomes.
The global Medical Bioplastic market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global medical bioplastics market has been experiencing steady growth in recent years. The increasing demand for sustainable and environmentally friendly materials in the healthcare sector, coupled with the growing awareness of plastic waste reduction, has been driving market expansion. Medical bioplastics have a wide range of applications in the healthcare industry, including surgical instruments, implantable devices, drug delivery systems, wound care products, orthopedic implants, and disposable medical supplies. The market growth is fueled by the demand for biocompatible, lightweight, and customizable materials that offer improved performance in medical devices.
This report aims to provide a comprehensive presentation of the global market for Medical Bioplastic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Medical Bioplastic.
Report Scope
The Medical Bioplastic market size, estimations, and forecasts are provided in terms of output/shipments (Kiloton) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Medical Bioplastic market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Medical Bioplastic manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
麻豆原创 Segmentation
By Company
BASF
Mitsubishi Chemical
Eastman
Futamura Group
Neste
TotalEnergies Corbion
NatureWorks
DSM
Braskem
Corbion
Evonik
Bormioli Pharma
Biome Bioplastics
Novamont
Segment by Type
Bio-PE
Regenerated Cellulose
Poly Hydroxyalkonoates
Polylactic Acid (PLA)
Others
Segment by Application
Wound Management
Drug Delivery
Orthopedic Instruments
Fiber And Porous Scaffolds
Pharmaceutical Packaging
Others
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Medical Bioplastic manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Medical Bioplastic by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Medical Bioplastic in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Medical Bioplastic 麻豆原创 Overview
1.1 Product Definition
1.2 Medical Bioplastic Segment by Type
1.2.1 Global Medical Bioplastic 麻豆原创 Value Growth Rate Analysis by Type 2023 VS 2030
1.2.2 Bio-PE
1.2.3 Regenerated Cellulose
1.2.4 Poly Hydroxyalkonoates
1.2.5 Polylactic Acid (PLA)
1.2.6 Others
1.3 Medical Bioplastic Segment by Application
1.3.1 Global Medical Bioplastic 麻豆原创 Value Growth Rate Analysis by Application: 2023 VS 2030
1.3.2 Wound Management
1.3.3 Drug Delivery
1.3.4 Orthopedic Instruments
1.3.5 Fiber And Porous Scaffolds
1.3.6 Pharmaceutical Packaging
1.3.7 Others
1.4 Global 麻豆原创 Growth Prospects
1.4.1 Global Medical Bioplastic Production Value Estimates and Forecasts (2019-2030)
1.4.2 Global Medical Bioplastic Production Capacity Estimates and Forecasts (2019-2030)
1.4.3 Global Medical Bioplastic Production Estimates and Forecasts (2019-2030)
1.4.4 Global Medical Bioplastic 麻豆原创 Average Price Estimates and Forecasts (2019-2030)
1.5 Assumptions and Limitations
2 麻豆原创 Competition by Manufacturers
2.1 Global Medical Bioplastic Production 麻豆原创 Share by Manufacturers (2019-2024)
2.2 Global Medical Bioplastic Production Value 麻豆原创 Share by Manufacturers (2019-2024)
2.3 Global Key Players of Medical Bioplastic, Industry Ranking, 2022 VS 2023 VS 2024
2.4 Global Medical Bioplastic 麻豆原创 Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global Medical Bioplastic Average Price by Manufacturers (2019-2024)
2.6 Global Key Manufacturers of Medical Bioplastic, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Medical Bioplastic, Product Offered and Application
2.8 Global Key Manufacturers of Medical Bioplastic, Date of Enter into This Industry
2.9 Medical Bioplastic 麻豆原创 Competitive Situation and Trends
2.9.1 Medical Bioplastic 麻豆原创 Concentration Rate
2.9.2 Global 5 and 10 Largest Medical Bioplastic Players 麻豆原创 Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Medical Bioplastic Production by Region
3.1 Global Medical Bioplastic Production Value Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.2 Global Medical Bioplastic Production Value by Region (2019-2030)
3.2.1 Global Medical Bioplastic Production Value 麻豆原创 Share by Region (2019-2024)
3.2.2 Global Forecasted Production Value of Medical Bioplastic by Region (2025-2030)
3.3 Global Medical Bioplastic Production Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.4 Global Medical Bioplastic Production by Region (2019-2030)
3.4.1 Global Medical Bioplastic Production 麻豆原创 Share by Region (2019-2024)
3.4.2 Global Forecasted Production of Medical Bioplastic by Region (2025-2030)
3.5 Global Medical Bioplastic 麻豆原创 Price Analysis by Region (2019-2024)
3.6 Global Medical Bioplastic Production and Value, Year-over-Year Growth
3.6.1 North America Medical Bioplastic Production Value Estimates and Forecasts (2019-2030)
3.6.2 Europe Medical Bioplastic Production Value Estimates and Forecasts (2019-2030)
3.6.3 China Medical Bioplastic Production Value Estimates and Forecasts (2019-2030)
3.6.4 Japan Medical Bioplastic Production Value Estimates and Forecasts (2019-2030)
4 Medical Bioplastic Consumption by Region
4.1 Global Medical Bioplastic Consumption Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
4.2 Global Medical Bioplastic Consumption by Region (2019-2030)
4.2.1 Global Medical Bioplastic Consumption by Region (2019-2024)
4.2.2 Global Medical Bioplastic Forecasted Consumption by Region (2025-2030)
4.3 North America
4.3.1 North America Medical Bioplastic Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.3.2 North America Medical Bioplastic Consumption by Country (2019-2030)
4.3.3 United States
4.3.4 Canada
4.4 Europe
4.4.1 Europe Medical Bioplastic Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.4.2 Europe Medical Bioplastic Consumption by Country (2019-2030)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Medical Bioplastic Consumption Growth Rate by Region: 2019 VS 2023 VS 2030
4.5.2 Asia Pacific Medical Bioplastic Consumption by Region (2019-2030)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Medical Bioplastic Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.6.2 Latin America, Middle East & Africa Medical Bioplastic Consumption by Country (2019-2030)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
5 Segment by Type
5.1 Global Medical Bioplastic Production by Type (2019-2030)
5.1.1 Global Medical Bioplastic Production by Type (2019-2024)
5.1.2 Global Medical Bioplastic Production by Type (2025-2030)
5.1.3 Global Medical Bioplastic Production 麻豆原创 Share by Type (2019-2030)
5.2 Global Medical Bioplastic Production Value by Type (2019-2030)
5.2.1 Global Medical Bioplastic Production Value by Type (2019-2024)
5.2.2 Global Medical Bioplastic Production Value by Type (2025-2030)
5.2.3 Global Medical Bioplastic Production Value 麻豆原创 Share by Type (2019-2030)
5.3 Global Medical Bioplastic Price by Type (2019-2030)
6 Segment by Application
6.1 Global Medical Bioplastic Production by Application (2019-2030)
6.1.1 Global Medical Bioplastic Production by Application (2019-2024)
6.1.2 Global Medical Bioplastic Production by Application (2025-2030)
6.1.3 Global Medical Bioplastic Production 麻豆原创 Share by Application (2019-2030)
6.2 Global Medical Bioplastic Production Value by Application (2019-2030)
6.2.1 Global Medical Bioplastic Production Value by Application (2019-2024)
6.2.2 Global Medical Bioplastic Production Value by Application (2025-2030)
6.2.3 Global Medical Bioplastic Production Value 麻豆原创 Share by Application (2019-2030)
6.3 Global Medical Bioplastic Price by Application (2019-2030)
7 Key Companies Profiled
7.1 BASF
7.1.1 BASF Medical Bioplastic Corporation Information
7.1.2 BASF Medical Bioplastic Product Portfolio
7.1.3 BASF Medical Bioplastic Production, Value, Price and Gross Margin (2019-2024)
7.1.4 BASF Main Business and 麻豆原创s Served
7.1.5 BASF Recent Developments/Updates
7.2 Mitsubishi Chemical
7.2.1 Mitsubishi Chemical Medical Bioplastic Corporation Information
7.2.2 Mitsubishi Chemical Medical Bioplastic Product Portfolio
7.2.3 Mitsubishi Chemical Medical Bioplastic Production, Value, Price and Gross Margin (2019-2024)
7.2.4 Mitsubishi Chemical Main Business and 麻豆原创s Served
7.2.5 Mitsubishi Chemical Recent Developments/Updates
7.3 Eastman
7.3.1 Eastman Medical Bioplastic Corporation Information
7.3.2 Eastman Medical Bioplastic Product Portfolio
7.3.3 Eastman Medical Bioplastic Production, Value, Price and Gross Margin (2019-2024)
7.3.4 Eastman Main Business and 麻豆原创s Served
7.3.5 Eastman Recent Developments/Updates
7.4 Futamura Group
7.4.1 Futamura Group Medical Bioplastic Corporation Information
7.4.2 Futamura Group Medical Bioplastic Product Portfolio
7.4.3 Futamura Group Medical Bioplastic Production, Value, Price and Gross Margin (2019-2024)
7.4.4 Futamura Group Main Business and 麻豆原创s Served
7.4.5 Futamura Group Recent Developments/Updates
7.5 Neste
7.5.1 Neste Medical Bioplastic Corporation Information
7.5.2 Neste Medical Bioplastic Product Portfolio
7.5.3 Neste Medical Bioplastic Production, Value, Price and Gross Margin (2019-2024)
7.5.4 Neste Main Business and 麻豆原创s Served
7.5.5 Neste Recent Developments/Updates
7.6 TotalEnergies Corbion
7.6.1 TotalEnergies Corbion Medical Bioplastic Corporation Information
7.6.2 TotalEnergies Corbion Medical Bioplastic Product Portfolio
7.6.3 TotalEnergies Corbion Medical Bioplastic Production, Value, Price and Gross Margin (2019-2024)
7.6.4 TotalEnergies Corbion Main Business and 麻豆原创s Served
7.6.5 TotalEnergies Corbion Recent Developments/Updates
7.7 NatureWorks
7.7.1 NatureWorks Medical Bioplastic Corporation Information
7.7.2 NatureWorks Medical Bioplastic Product Portfolio
7.7.3 NatureWorks Medical Bioplastic Production, Value, Price and Gross Margin (2019-2024)
7.7.4 NatureWorks Main Business and 麻豆原创s Served
7.7.5 NatureWorks Recent Developments/Updates
7.8 DSM
7.8.1 DSM Medical Bioplastic Corporation Information
7.8.2 DSM Medical Bioplastic Product Portfolio
7.8.3 DSM Medical Bioplastic Production, Value, Price and Gross Margin (2019-2024)
7.8.4 DSM Main Business and 麻豆原创s Served
7.7.5 DSM Recent Developments/Updates
7.9 Braskem
7.9.1 Braskem Medical Bioplastic Corporation Information
7.9.2 Braskem Medical Bioplastic Product Portfolio
7.9.3 Braskem Medical Bioplastic Production, Value, Price and Gross Margin (2019-2024)
7.9.4 Braskem Main Business and 麻豆原创s Served
7.9.5 Braskem Recent Developments/Updates
7.10 Corbion
7.10.1 Corbion Medical Bioplastic Corporation Information
7.10.2 Corbion Medical Bioplastic Product Portfolio
7.10.3 Corbion Medical Bioplastic Production, Value, Price and Gross Margin (2019-2024)
7.10.4 Corbion Main Business and 麻豆原创s Served
7.10.5 Corbion Recent Developments/Updates
7.11 Evonik
7.11.1 Evonik Medical Bioplastic Corporation Information
7.11.2 Evonik Medical Bioplastic Product Portfolio
7.11.3 Evonik Medical Bioplastic Production, Value, Price and Gross Margin (2019-2024)
7.11.4 Evonik Main Business and 麻豆原创s Served
7.11.5 Evonik Recent Developments/Updates
7.12 Bormioli Pharma
7.12.1 Bormioli Pharma Medical Bioplastic Corporation Information
7.12.2 Bormioli Pharma Medical Bioplastic Product Portfolio
7.12.3 Bormioli Pharma Medical Bioplastic Production, Value, Price and Gross Margin (2019-2024)
7.12.4 Bormioli Pharma Main Business and 麻豆原创s Served
7.12.5 Bormioli Pharma Recent Developments/Updates
7.13 Biome Bioplastics
7.13.1 Biome Bioplastics Medical Bioplastic Corporation Information
7.13.2 Biome Bioplastics Medical Bioplastic Product Portfolio
7.13.3 Biome Bioplastics Medical Bioplastic Production, Value, Price and Gross Margin (2019-2024)
7.13.4 Biome Bioplastics Main Business and 麻豆原创s Served
7.13.5 Biome Bioplastics Recent Developments/Updates
7.14 Novamont
7.14.1 Novamont Medical Bioplastic Corporation Information
7.14.2 Novamont Medical Bioplastic Product Portfolio
7.14.3 Novamont Medical Bioplastic Production, Value, Price and Gross Margin (2019-2024)
7.14.4 Novamont Main Business and 麻豆原创s Served
7.14.5 Novamont Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Medical Bioplastic Industry Chain Analysis
8.2 Medical Bioplastic Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Medical Bioplastic Production Mode & Process
8.4 Medical Bioplastic Sales and 麻豆原创ing
8.4.1 Medical Bioplastic Sales Channels
8.4.2 Medical Bioplastic Distributors
8.5 Medical Bioplastic Customers
9 Medical Bioplastic 麻豆原创 Dynamics
9.1 Medical Bioplastic Industry Trends
9.2 Medical Bioplastic 麻豆原创 Drivers
9.3 Medical Bioplastic 麻豆原创 Challenges
9.4 Medical Bioplastic 麻豆原创 Restraints
10 Research Finding and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 麻豆原创 Size Estimation
11.1.3 麻豆原创 Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer

Companies Mentioned:

BASF
Mitsubishi Chemical
Eastman
Futamura Group
Neste
TotalEnergies Corbion
NatureWorks
DSM
Braskem
Corbion
Evonik
Bormioli Pharma
Biome Bioplastics
Novamont

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.